This interactive session includes panelists representing advanced fellows and academic faculty who are available to answer participants' questions regarding diverse pathways for hepatology training and research opportunities as well as the ins and outs of finding training opportunities and employment. Discussion topics include: advanced and transplant hepatology fellowships; finding a gastrointestinal (GI) fellowship; GI clinical research fellowships; hepatology training as an international medical graduate; American Board of Internal Medicine's fast-track hepatology fellowship; hepatology training before GI fellowship; informatics and hepatology; finding a niche; finding a mentor; and finding a hepatology job.

This engaging symposium will provide insights into recent innovations in the management of chronic hepatitis B. Expert faculty will discuss emerging biomarkers, investigational therapies aimed at chronic viral suppression and functional cure, and how these advances may help address existing gaps in care and improve long-term patient outcomes.

Supported by: Aligos Therapeutics
Organized by: Clinical Care Options, LLC

For more information and to register, visit: https://clinicaloptions.com/events/hbv-innovations/hbv-innovations/22094-36992

Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.

Join us for a poster highlight of the top abstracts from the HepTox SIG. 
 

Developed by the Patient Advisory Group, this session explores MASLD and MASH from adolescence to adulthood, including approaches to improve treatment outcomes and strategies for early adoption of exercise and nutrition plans.

Join our Latin American leadership and members for a casual meet-up at The Park—a new networking opportunity designed for connection and conversation. Come enjoy an hour of socializing, light snacks, and great company!

National Institute of Alcohol Abuse and Alcoholism Director, Dr. George Koob, will present opening remarks on NIAAA's liver-related work, present on research opportunities, and answer audience questions.

This interactive symposium will enhance knowledge of MASH diagnosis, risk stratification, and treatment. Expert-led sessions will review noninvasive diagnostic tools, guideline-driven staging, lifestyle interventions, and emerging therapies. Case-based discussions will engage learners in applying concepts to clinical scenarios and addressing real-world challenges in the diagnosis and proactive management of MASH.

Supported by: Novo Nordisk

Organized by: Med Learning Group 

Link: https://www.medlearninggroup.com/cme-programming/mash-sympo/

Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.

This community conversation brings together a diverse group of hepatology experts and advanced practice providers (APPs) to discuss the integral role APPs play in the multidisciplinary care of patients with liver disease. The discussion showcases how APPs contribute to improving patient outcomes, fostering innovative care models, and addressing challenges in the management of liver conditions.

Presenters in this symposium focus on the varied functions of liver endothelial cells (ECs). ECs are specialized cells increasingly recognized for their heterogeneity and their key role in liver diseases and carcinogenesis. Recent advances in the understanding of EC function were made possible with refined isolation techniques coupled with multiomics studies. Speakers review emerging literature that defines liver ECs beyond their role as vascular barriers to critical mediators in various biological processes under physiologic and pathologic conditions. 

Developed by the Patient Advisory Group, specialists in the cholestatic liver diseases primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) collaborate with patient advocates to shine a light on: (1) newly available treatments for PBC; (2) a new tool for patients to use during their first visit with their hepatologist; (3) an exciting registry for patients with PSC; and (4) what patients need to know about symptom management.